Leukocare Logo
Live Webinar

Making formulation
decisions you can
defend.

Real-world biologics insights into late-stage development under commercialisation pressure.

June 11, 2026
4:00 PM CEST
10:00 AM ET
60 minutes
Live Q&A included

Join the live discussion.

Save your seat and receive practical insights you can apply in your development programs.

We look forward to your participation.

The challenge

Why this matters now

As late-stage programs evolve, formulation decisions suddenly carry broader technical, operational and commercial consequences.

Teams are expected to move faster, reduce uncertainty, scale confidently and defend decisions across multiple stakeholders.

 

More data alone does not automatically create confidence.

 
What you will learn

In this webinar, you will learn

 
How teams generate decision-ready formulation data
 
How to reduce uncertainty in complex biologics programs
 
How structured DoE approaches support confident decision making
 
How to balance speed, robustness and long-term development goals

Who should attend?

CMC Leaders
Formulation Scientists
Pharmaceutical Development Teams
Technical Operations
Biologics Development Leaders
Asset / Program Leaders

Real-world insights.
Practical perspectives.

A conversation between a late-stage biologics development perspective and an industry expert in formulation strategy and experimental design.

 
Late-stage biologics
development perspective

Experience from a late-stage program in biologics development — bringing a practitioner's view on formulation decisions under real commercial pressure.

 
Cornelius Pompe
COO, Leukocare

Expert in formulation strategy, DoE and data-driven decision making for biologics programs at all development stages.

Live Q&A
Get your questions answered
Real cases
Learn from real-world experience
Actionable insights
Take ideas back to your team